Diabetic Macular Edema (DME) Completed Phase 2 Trials for Nepafenac (DB06802)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01331005NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)Treatment